Loading...
Polymorphisms within the and Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium.
ánchez-Maldonado, Jose Manuel Moñiz-Díez, Ana Rob Ter Horst, Daniele Campa Cabrera-Serrano, Antonio José Garrido-Collado, María Del Pilar Hernández-Mohedo, Fracisca Fernández-Puerta, Laura López-Nevot, , Miguel Ángel Cunha, Ctistina González-Sierra, Pedro Antonio
ánchez-Maldonado, Jose Manuel
Moñiz-Díez, Ana
Rob Ter Horst, Daniele Campa
Cabrera-Serrano, Antonio José
Garrido-Collado, María Del Pilar
Hernández-Mohedo, Fracisca
Fernández-Puerta, Laura
López-Nevot, , Miguel Ángel
Cunha, Ctistina
González-Sierra, Pedro Antonio
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-12-23
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 1.32 MB
Other Titles
Abstract
Here, we assessed whether 36 single nucleotide polymorphisms (SNPs) within the TNFSF4 and MAPKAPK2 loci influence the risk of developing invasive aspergillosis (IA). We conducted a two-stage case control study including 911 high-risk patients diagnosed with hematological malignancies that were ascertained through the aspBIOmics consortium. The meta-analysis of the discovery and replication populations revealed that carriers of the TNFSF4rs7526628T/T genotype had a significantly increased risk of developing IA (p = 0.00022). We also found that carriers of the TNFSF4rs7526628T allele showed decreased serum levels of TNFSF14 protein (p = 0.0027), and that their macrophages had a decreased fungicidal activity (p = 0.048). In addition, we observed that each copy of the MAPKAPK2rs12137965G allele increased the risk of IA by 60% (p = 0.0017), whereas each copy of the MAPKAPK2rs17013271T allele was estimated to decrease the risk of developing the disease (p = 0.0029). Mechanistically, we found that carriers of the risk MAPKAPK2rs12137965G allele showed increased numbers of CD38+IgM-IgD- plasmablasts in blood (p = 0.00086), whereas those harboring two copies of the allele had decreased serum concentrations of thymic stromal lymphopoietin (p = 0.00097). Finally, we also found that carriers of the protective MAPKAPK2rs17013271T allele had decreased numbers of CD27-IgM-IgD- B cells (p = 0.00087) and significantly lower numbers of CD14+ and CD14+CD16- cells (p = 0.00018 and 0.00023). Altogether, these results suggest a role of the TNFSF4 and MAPKAPK2 genes in determining IA risk.
Citation
. J Fungi (Basel). 2020 Dec 23;7(1):E4. doi: 10.3390/jof7010004.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
2309-608X
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International